(Q36379530)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22987753%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

title

Back to the future: a new 'old' lead for tuberculosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22987753%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22987753%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Gerard D Wright

1 reference

13 August 2017

17 September 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22987753%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

published in

EMBO Molecular Medicine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22987753%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22987753%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22987753%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

page(s)

1029-1031

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22987753%20AND%20SRC:MED&resulttype=core&format=json

Towards a new tuberculosis drug: pyridomycin - nature's isoniazid

13 February 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3491833

Drug-resistant tuberculosis--current dilemmas, unanswered questions, challenges, and priority needs

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3491833

Fix the antibiotics pipeline.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3491833

Antibiotics for emerging pathogens

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3491833

Natural products to drugs: daptomycin and related lipopeptide antibiotics

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3491833

Bioactive microbial metabolites

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3491833

The isoniazid-NAD adduct is a slow, tight-binding inhibitor of InhA, the Mycobacterium tuberculosis enoyl reductase: adduct affinity and drug resistance

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3491833

Modification of the NADH of the Isoniazid Target (InhA) from Mycobacterium tuberculosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3491833

30 September 2017

Antibiotics: a new hope

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FEMMM.201201811

Streptomycin, a Substance Exhibiting Antibiotic Activity Against Gram-Positive and Gram-Negative Bacteria.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FEMMM.201201811

21 January 2018

Identifiers

DOI

10.1002/EMMM.201201811

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22987753%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22987753%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

PubMed publication ID

22987753

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22987753%20AND%20SRC:MED&resulttype=core&format=json